Evidence map›Paper›PMID 24626789›Full record

Trial reportThe American journal of psychiatry2014

Pharmacotherapy and family-focused treatment for adolescents with bipolar I and II disorders: a 2-year randomized trial.

David J Miklowitz, Christopher D Schneck, Elizabeth L George, Dawn O Taylor, Catherine A Sugar, Boris Birmaher, Robert A Kowatch, Melissa P DelBello, David A Axelson

3 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00332098 phase3completednot on this map

Family-Focused Treatment for Bipolar Adolescents

TypeinterventionalSponsorUniversity of California, Los AngelesRan2006 to 2012Enrolled145ConditionsBipolar DisorderArmsFamily-Focused Treatment Plus Pharmacotherapy, Enhanced Care Plus Pharmacotherapy
NCT05427123 recruitingnot on this mapstarted 2022, after this paper: background citation

A Collaborative Treatment Network for Youth With or at High Risk for Bipolar Disorder

TypeobservationalSponsorUniversity of California, Los AngelesRan2022 to 2027Enrolled80ConditionsBipolar Disorder, Bipolar I Disorder, Bipolar II Disorder, Other Specified Bipolar and Related DisorderArmsMedication or psychosocial treatment
NCT06920940 narecruitingnot on this mapstarted 2025, after this paper: background citation

Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

TypeinterventionalSponsorUniversity of California, Los AngelesRan2025 to 2027Enrolled80ConditionsBipolar Disorder (BD), Bipolar Disorder NOS, Bipolar Disorder I or II, Bipolar Spectrum DisorderArmsKetogenic Therapy
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Classifying Mood Symptom Trajectories in Adolescents With Bipolar Disorder.Journal of the American Academy of Child and Adolescent Psychiatry · 2020
    Trial
  16. Trial
  17. A Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder.Journal of child and adolescent psychopharmacology · 2017
    Trial
  18. Trial
  19. Trial
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

David J Miklowitz
Christopher D Schneck
Elizabeth L George
Dawn O Taylor
Catherine A Sugar
Boris Birmaher
Robert A Kowatch
Melissa P DelBello
David A Axelson
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati Medical Center · USUniversity of California, Los Angeles · USUniversity of Pittsburgh · US

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
1/2-Early Intervention for Youth at Risk for Bipolar DisorderR01MH093676 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MIKLOWITZ, DAVID JAY · 2012 to 2016
$3.6M
Family-Focused Treatment for Bipolar AdolescentsR01MH073817 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AXELSON, DAVID A · 2006 to 2010
$1.7M
Family-Focused Treatment for Bipolar AdolescentsR01MH073871 · NIMH · UNIVERSITY OF COLORADO · PI MIKLOWITZ, DAVID JAY · 2006 to 2010
$1.7M
Family-Focused Treatment for Bipolar AdolescentsR01MH074033 · NIMH · CINCINNATI CHILDRENS HOSP MED CTR · PI KOWATCH, ROBERT ANTHONY · 2006 to 2010
$1.3M
Family-Focused Therapy for Youth with Early-Onset Bipolar or Psychotic Disorders R33MH097007 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MIKLOWITZ, DAVID JAY · 2014 to 2016
$853k
Family-Focused Therapy as Early Treatment for Youth at Risk for Bipolar DisorderR34MH077856 · NIMH · UNIVERSITY OF COLORADO · PI MIKLOWITZ, DAVID JAY · 2007 to 2009
$638k
Family-Focused Treatment for Youth with Early-Onset Bipolar or Psychotic DisorderR21MH097007 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MIKLOWITZ, DAVID JAY · 2012 to 2013
$439k
NCATS NIH HHS UL1 TR001425NIMH NIH HHS R01 MH073817NIMH NIH HHS R01MH073817NIMH NIH HHS R01 MH073871NIMH NIH HHS R01 MH074033NIMH NIH HHS R01MH074033NIMH NIH HHS R01 MH093676NIMH NIH HHS R21 MH097007NIMH NIH HHS R33 MH097007NIMH NIH HHS R34 MH077856NIMH NIH HHS R34MH077856
6 · The paper itself

Abstract

objectivePrevious studies have found that family-focused treatment is an effective adjunct to pharmacotherapy in stabilizing symptoms in adult bipolar disorder. The authors examined whether pharmacotherapy and family-focused treatment for adolescents with bipolar disorder was more effective than pharmacotherapy and brief psychoeducation (enhanced care) in decreasing time to recovery from a mood episode, increasing time to recurrence, and reducing symptom severity over 2 years.

methodA total of 145 adolescents (mean age, 15.6 years) with bipolar I or II disorder and a DSM-IV-TR manic, hypomanic, depressive, or mixed episode in the previous 3 months were randomly assigned, with family members, either to pharmacotherapy and family-focused treatment, consisting of psychoeducation (i.e., recognition and early intervention with prodromal symptoms), communication enhancement training, and problem-solving skills training, delivered in 21 sessions over 9 months; or to pharmacotherapy and three weekly sessions of enhanced care (family psychoeducation). Independent evaluators assessed participants at baseline, every 3 months during year 1, and every 6 months during year 2, using weekly ratings of mood.

resultsTwenty-two participants (15.2%) withdrew shortly after randomization. Time to recovery or recurrence and proportion of weeks ill did not differ between the two treatment groups. Secondary analyses revealed that participants in family-focused treatment had less severe manic symptoms during year 2 than did those in enhanced care.

conclusionsAfter an illness episode, intensive psychotherapy combined with best-practice pharmacotherapy does not appear to confer advantages over brief psychotherapy and pharmacotherapy in hastening recovery or delaying recurrence among adolescents with bipolar disorder.

Indexed as

AdolescentAntipsychotic AgentsBipolar DisorderFamily TherapyFemaleHumansMalePsychiatric Status Rating ScalesPsychotherapy, BriefTime FactorsTreatment OutcomeAntipsychotic Agents

Identifiers

PMID24626789
PMCPMC4083000
OpenAlexW2120909975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.